Cancer biotech ImmVirX taps Bell Potter for $20m pre-IPO
SYDNEY: The team behind ex-ASX listed biotech Viralytics – which was bought by global pharma
SYDNEY: The team behind ex-ASX listed biotech Viralytics – which was bought by global pharma
FEATURED
Green light for 100% social rent extension of extra care facility
Best affordable seniors housing design for Global Awards shortlisted
Work on 56 unit social and affordable housing scheme to begin
Farmhouse with ex-ballroom becomes supported social housing hub
Scheme allows care providers to make ‘virtual visits’ to innovation hubs
Housing complex now largest after 65-apartment expansion
INNOVATION
